VIITAL

Serial Number 97596771
733

Registration Progress

Application Filed
Sep 19, 2022
Under Examination
Oct 17, 2023
Approved for Publication
Aug 22, 2023
Published for Opposition
Aug 22, 2023
Registered

Trademark Image

VIITAL

Basic Information

Serial Number
97596771
Filing Date
September 19, 2022
Published for Opposition
August 22, 2023
Drawing Code
5

Status Summary

Current Status
Active
Status Code
733
Status Date
Oct 17, 2025
Application
Pending
Classes
044

Rights Holder

Abeona Therapeutics Inc.

03
Address
1330 Avenue of the Americas
New York, NY 10019

Ownership History

Abeona Therapeutics Inc.

Original Applicant
03
New York, NY

Abeona Therapeutics Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Nels Lippert

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Oct 18, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 17, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 17, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 17, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 17, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 16, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 16, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 16, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 16, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 16, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 16, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 16, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 11, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 10, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 10, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 10, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 17, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 17, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 17, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 22, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 22, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 2, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 20, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 11, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 10, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 10, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 7, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 7, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 7, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 29, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 4, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 22, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Providing pharmaceutical information on the efficacy of a gene therapy preparation for the treatment of recessive dystrophic epidermolysis bullosa

Additional Information

Design Mark
The mark consists of the word VIITAL with the VII in green and the TAL in blue. The color white represents background and is not claimed as a feature of the mark.
Color Claim
The color(s) green and blue is/are claimed as a feature of the mark.

Classification

International Classes
044